Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $59.3 million.

  • Puma Biotechnology's Non-Current Assets fell 723.27% to $59.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.0 million, marking a year-over-year decrease of 1073.04%. This contributed to the annual value of $65.7 million for FY2024, which is 1165.95% down from last year.
  • Latest data reveals that Puma Biotechnology reported Non-Current Assets of $59.3 million as of Q3 2025, which was down 723.27% from $58.3 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Non-Current Assets ranged from a high of $94.9 million in Q1 2021 and a low of $58.3 million during Q2 2025
  • In the last 5 years, Puma Biotechnology's Non-Current Assets had a median value of $78.3 million in 2023 and averaged $76.7 million.
  • As far as peak fluctuations go, Puma Biotechnology's Non-Current Assets surged by 4195.49% in 2021, and later tumbled by 1833.46% in 2024.
  • Over the past 5 years, Puma Biotechnology's Non-Current Assets (Quarter) stood at $86.6 million in 2021, then increased by 1.4% to $87.8 million in 2022, then dropped by 15.31% to $74.3 million in 2023, then fell by 11.66% to $65.7 million in 2024, then fell by 9.73% to $59.3 million in 2025.
  • Its Non-Current Assets stands at $59.3 million for Q3 2025, versus $58.3 million for Q2 2025 and $63.7 million for Q1 2025.